These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 20570493)

  • 1. Psychiatrists' attitude to antipsychotic depot treatment in patients with first-episode schizophrenia.
    Heres S; Reichhart T; Hamann J; Mendel R; Leucht S; Kissling W
    Eur Psychiatry; 2011; 26(5):297-301. PubMed ID: 20570493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attitudes of psychiatrists toward antipsychotic depot medication.
    Heres S; Hamann J; Kissling W; Leucht S
    J Clin Psychiatry; 2006 Dec; 67(12):1948-53. PubMed ID: 17194274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Psychiatrists' decision making and monitoring of antipsychotic prescription for elderly schizophrenia patients].
    Jalenques I; Ortega V; Legrand G; Auclair C
    Encephale; 2016 Apr; 42(2):124-9. PubMed ID: 26796558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychiatrists' attitudes to maintenance medication for patients with schizophrenia.
    Patel MX; Nikolaou V; David AS
    Psychol Med; 2003 Jan; 33(1):83-9. PubMed ID: 12537039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatrists' Attitude and Use of Second-generation Antipsychotics for the Treatment of Schizophrenia in Taiwan.
    Chen CK; Su HH; Sun IW
    East Asian Arch Psychiatry; 2017 Sep; 27(3):91-6. PubMed ID: 28993541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attitudes towards long-acting depot antipsychotics: a survey of patients, relatives and psychiatrists.
    Jaeger M; Rossler W
    Psychiatry Res; 2010 Jan; 175(1-2):58-62. PubMed ID: 20004980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How much more effective do depot antipsychotics have to be compared to oral antipsychotics before they are prescribed?
    Hamann J; Mendel R; Heres S; Leucht S; Kissling W
    Eur Neuropsychopharmacol; 2010 Apr; 20(4):276-9. PubMed ID: 20133108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Checking the plausibility of psychiatrists׳ arguments for not prescribing depot medication.
    Hamann J; Kissling W; Heres S
    Eur Neuropsychopharmacol; 2014 Sep; 24(9):1506-10. PubMed ID: 25037772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oral versus long-acting antipsychotics on social functioning: A psychiatrists' survey in India.
    Gundugurti PR; Nagpal R; Sheth A; Narang P; Gawande S; Singh V
    Asian J Psychiatr; 2017 Dec; 30():88-93. PubMed ID: 28843143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [French Society for Biological Psychiatry and Neuropsychopharmacology task force: Formal Consensus for the prescription of depot antipsychotics].
    Samalin L; Abbar M; Courtet P; Guillaume S; Lancrenon S; Llorca PM
    Encephale; 2013 Dec; 39 Suppl 4():189-203. PubMed ID: 24373464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatrists' use, knowledge and attitudes to first- and second-generation antipsychotic long-acting injections: comparisons over 5 years.
    Patel MX; Haddad PM; Chaudhry IB; McLoughlin S; Husain N; David AS
    J Psychopharmacol; 2010 Oct; 24(10):1473-82. PubMed ID: 19477883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying the profile of optimal candidates for antipsychotic depot therapy A cluster analysis.
    Heres S; Hamann J; Mendel R; Wickelmaier F; Pajonk FG; Leucht S; Kissling W
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1987-93. PubMed ID: 18948163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survey on schizophrenia treatment in Mexico: perception and antipsychotic prescription patterns.
    Apiquian R; Fresán A; de la Fuente-Sandoval C; Ulloa RE; Nicolini H
    BMC Psychiatry; 2004 Apr; 4():12. PubMed ID: 15109398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychiatrists' attitude towards the use of clozapine in the treatment of refractory schizophrenia: A nationwide survey.
    Daod E; Krivoy A; Shoval G; Zubedat S; Lally J; Vadas L; Weizman A; Reshef A; Bloch B
    Psychiatry Res; 2019 May; 275():155-161. PubMed ID: 30913436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychiatrists' attitudes toward metabolic adverse events in patients with schizophrenia.
    Sugawara N; Yasui-Furukori N; Yamazaki M; Shimoda K; Mori T; Sugai T; Suzuki Y; Someya T
    PLoS One; 2014; 9(1):e86826. PubMed ID: 24466260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The attitude of patients towards antipsychotic depot treatment.
    Heres S; Schmitz FS; Leucht S; Pajonk FG
    Int Clin Psychopharmacol; 2007 Sep; 22(5):275-82. PubMed ID: 17690596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naturalistic, retrospective comparison between second-generation antipsychotics and depot neuroleptics in patients affected by schizophrenia.
    Marchiaro L; Rocca P; LeNoci F; Longo P; Montemagni C; Rigazzi C; Bogetto F
    J Clin Psychiatry; 2005 Nov; 66(11):1423-31. PubMed ID: 16420080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of depot antipsychotics in Belgium between 1997 and 2016].
    Tielens S; Destoop M; Morrens M
    Tijdschr Psychiatr; 2021; 63(9):630-637. PubMed ID: 34647300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Influence of Genotype Information on Psychiatrists' Treatment Recommendations: More Experienced Clinicians Know Better What to Ignore.
    McMichael AJ; Boeri M; Rolison JJ; Kane J; O'Neill FA; Scarpa R; Kee F
    Value Health; 2017 Jan; 20(1):126-131. PubMed ID: 28212953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antipsychotics in clinical practice. Treatment of the first schizophrenic episode].
    Jarema M; Meder J; Araszkiewicz A; Tyszkowska M
    Psychiatr Pol; 2008; 42(6):841-58. PubMed ID: 19441663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.